Follow

Submissions from 2024

First-in-human Phase I Trial of TPST-1120, an Inhibitor of PPARα, as Monotherapy or in Combination with Nivolumab, in Patients with Advanced Solid Tumors, Bruno Bastos

Pharmacodynamics and Gene Expression Analysis of Patients with Renal Cell Carcinoma Treated with Combination Nivolumab and TPST-1120 in a Phase I Clinical Trial (NCT03829436), Bruno Bastos

Phase I Study of Elraglusib (9-ING-41), a Glycogen Synthase Kinase-3β Inhibitor, as Monotherapy or Combined with Chemotherapy in Patients with Advanced Malignancies, Bruno Bastos

Impact of TP53, RB1, and PTEN Mutations on Overall Survival in Metastatic Prostate Cancer: A Multi-center Study Via the Guardian Research Network., Mohammad Ganiyani, Pushan Prabhakar, Atulya Khosla, Shreyas Bellur, Arjun Avudaiappan, Bruno Bastos, and Rohan Garje

Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study, Guenther Koehne

A Machine Learning Approach To Predict Mortality Due To Immune-Mediated Thrombotic Thrombocytopenic Purpura, Camila Masias

Irreversible Electroporation in Treating Colorectal Liver Metastases in Proximity to Critical Structures, Govindarajan Narayanan, Nicole Gentile, Jonathan Eyshi, Brian Schiro, Ripal Gandhi, Constantino Pena, Antonio Ucar, Santiago Aparo, Fernando de Zarraga, Sarah Joseph, Horacio Asbun, and Madelon Dijkstra

Pan-Cancer Interrogation of B7-H3 (CD276) as an Actionable Therapeutic Target Across Human Malignancies, Garje Rohan

Modified FOLFOX6 plus bevacizumab with and without nivolumab for first-line treatment of metastatic colorectal cancer: phase 2 results from the CheckMate 9X8 randomized clinical trial, Antonio Ucar

Submissions from 2023

Prognostic value of neutrophil/lymphocyte count in pancreas patients receiving ablative MR-guided RT, Michael Chuong, Robert Herrera, Muni Rubens, Antonio Ucar, Fernando De Zarraga, Santiago Aparo, Sarah Joseph, Matthew Hall, Rupesh Kotecha, Adeel Kaiser, and Gigi Estevez

Phase II trial of single-fraction SABR on 0.35T MRI-linac for thoracic, abdominal, and pelvic tumors, Michael Chuong, Kathryn Mittauer, Martin Tom, Noah Kalman, James McCulloch, Diane Alvarez, Paul Kaywin, Antonio Ucar, Federico Albrecht, Fernando De Zarraga, Santiago Aparo, Guilherme Rabinowits, Muni Rubens, Alonso Gutierrez, Rupesh Kotecha, and Carolina Rojas

Prospective Study Phase II Trial of Stereotactic MRI-Guided Adaptive Radiotherapy in 1 Fraction: Unplanned Interim Analysis, Michael Chuong, Kathryn Mittauer, Martin Tom, Noah Kalman, James McCulloch, Diane Alvarez, Paul Kaywin, Antonio Ucar, Federico Albrecht, Fernando De Zarraga, Santiago Aparo, Muni Rubens, Alonso Gutierrez, and Rupesh Kotecha

Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART), Roberto Herrera, Muni Rubens, Adeel Kaiser, Antonio Ucar, Fernando De Zarraga, Santiago Aparo, Horacio Asbun, Ramon Jimenez, and Michael Chuong

Elranatamab in relapsed or refractory multiple myeloma: phase 2 MagnetisMM-3 trial results, Guenther Koehne

PDF

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant, Guenther Koehne

Submissions from 2022

Causes of death among inoperable pancreas cancer patients receiving 5-fraction ablative magnetic resonance image-guided radiation therapy prescribed to median biologically effective dose of 100 Gy, Michael Chuong, Robert Herrera, Matthew Hall, Rupesh Kotecha, Antonio Ucar, Fernando De Zarraga, Santiago Aparo, Govindarajan Narayanan, Horacio Asbun, Ramon Jimenez, Kathryn Mittauer, Alonso Gutierrez, Diane Alvarez, Tino Romaguera, James McCulloch, and Adeel Kaiser

Induction Chemotherapy and Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy for Inoperable Pancreas Cancer, Michael Chuong; Roberto Herrera; Adeel Kaiser; Muni Rubens; Tino Romaguera; Diane Alvarez; Rupesh Kotecha; Matthew Hall; James McCulloch; Antonio Ucar; Santiago Aparo; Sarah Joseph; Horacio Asbun; Ramon Jimenez; Govindarajan Narayanan; Alonso Gutierrez; and Kathryn , Mittauer

Induction chemotherapy and ablative 5-fraction stereotactic magnetic resonance guided adaptive radiation therapy for patients with initially inoperable adenocarcinoma of the pancreas, Michael Chuong, Robert Herrera, Muni Rubens, Adeel Kaiser, Rupesh Kotecha, Matthew Hall, James McCulloch, Antonio Ucar, Fernando De Zarraga, Santiago Aparo, Horacio Asbun, Domenech Asbun, Ramon Jimenez, Govindarajan Narayanan, Tino Romaguera, Diane Alvarez, Alonso Gutierrez, and Kathryn Mittauer

Management of bleeding risk in patients who receive anticoagulant therapy for venous thromboembolism: Communication from the ISTH SSC Subcommittee on Predictive and Diagnostic Variables in Thrombotic Disease, Camila Masias Castanon

PDF

Race, Rituximab, and Relapse in TTP, Camila Masias Castanon

PDF

Efficacy and safety evaluation of avatrombopag in immune thrombocytopenia: analyses of a phase III study and long-term extension, Srikanth Nagalla

PDF

Evaluation of Anti-Factor Xa Level Usage for Low Molecular Weight Heparin in a Healthcare System, Natalie Quesep, Lourdes R. Menendez, Erika Dittmar, Radhan B. Gopalani, Payal Patel, and Srikanth Nagalla

Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer, Miguel Villalona Calero

Submissions from 2021

Mitigating the risk of transfusion-transmitted bacterial infections in hematology oncology patients, Harold Alvarez and Guenther Koehne

PDF

A randomized phase II study of coexpression extrapolation (COXEN) with neoadjuvant chemotherapy for bladder cancer (SWOG S1314; NCT02177695), Bruno Bastos

PDF

Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target, Bruno Bastos

OC-0415 Long-term outcomes of MR-guided SABR & on-table adaptive replanning for unresectable pancreas cancer, Michael Chuong, Kathryn Mittauer, Tino Romaguera, Diane Alvarez, Rupesh Kotecha, Matthew Hall, Adeel Kaiser, John Bryant, James McCulloch, Antonio Ucar, Horacio Asbun, Govindarajan Narayanan, Alonso Gutierrez, Muni Rubens, and Robert Herrera

PDF

Ocular outcomes after treatment of cytomegalovirus (CMV) retinitis using adoptive immunotherapy with CMV-specific cytotoxic T-lymphocytes, Guenther Koehne

PDF

Ocular Outcomes after Treatment of Cytomegalovirus Retinitis Using Adoptive Immunotherapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes, Guenther Koehne

PDF

Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease, Srikanth Nagalla

PDF

Perspectives on the quality and utility of letters conforming to the AAIM guidelines, Srikanth Nagalla

PDF

Malignant glioma subset from Actuate 1801: A phase 1/2 study of 9-ING-41, a glycogen synthase kinase 3 beta (GSK-3β) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory hematologic malignancies or solid tumors, Yazmin Odia and Bruno Bastos

Submissions from 2020

Phase I study of 9-ing-41, a small molecule selective glycogen synthase kinase-3 beta (GSK-3β) inhibitor, as a single agent and combined with chemotherapy, in patients with refractory tumors, Bruno Bastos

PDF

Randomized phase II trial and tumor mutational spectrum analysis from cabozantinib versus chemotherapy in metastatic uveal melanoma (Alliance A091201), Bruno Bastos

PDF

Case report of ablative magnetic resonance-guided stereotactic body radiation therapy for oligometastatic mesenteric lymph nodes from bladder cancer, Michael Chuong, Diane Alvarez, Tino Romaguera, Kathryn Mittauer, Sonia Adamson, Alonso Gutierrez, Gustavo Luciani, Hayden Guerrero Olmo, and Antonio Ucar

Abstract B054: Analysis of a cancer gene expression and next-generation sequencing dataset representing hispanic predominant South Florida population, Zuanel Diaz, Arpit Mehta, Zasha Pou, Muni Rubens, Don Parris, and Miguel Villalona Calero

PDF

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation, Guenther Koehne

PDF

Prognostic Factors for Post-Relapse Survival after ex-vivo CD34(+)-Selected (T cell-depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple Myeloma, Guenther Koehne

Emerging Ablative and Transarterial Therapies for Pancreatic Cancer, Govindarajan Narayanan, Antonio Ucar, Ripal Gandhi, Arian Nasiri, Prasuna Inampudi, and Horacio Asbun

PDF

Melflufen plus dexamethasone in relapsed and refractory multiple myeloma (O-12-M1): a multicentre, international, open-label, phase 1-2 study, Claudia Paba Prada

PDF

Evaluation of acute myeloid leukemia induction regimens in elderly patients with unfavorable risk cytogenetics that are candidates for intensive remission therapy, Monica Tadros, Guenther Koehne, Talia Zahra, Moe Shwin, Jessica Unzaga, and Nicholas Chow

Evaluating Acute Myeloid Leukemia Induction Regimens in Elderly Patients with Unfavorable Risk Cytogenetics That Are Candidates for Intensive Remission Therapy, Monica Tadros, Guenther Koehne, Talia Zahra, Jessica Unzaga, Moe Shwin, and Nicholas Chow

PDF

A Phase II Trial of Albumin-Bound Paclitaxel and Gemcitabine in Patients with Newly Diagnosed Stage IV Squamous Cell Lung Cancers, Miguel Villalona Calero

PDF

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology, Miguel Villalona Calero

PDF

Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study, Miguel Villalona Calero

Submissions from 2019

PDF

Complications of Intrathecal Chemotherapy in Adults: Single-Institution Experience in 109 Consecutive Patients, Fernando Vargas Madueno

PDF

Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer, Miguel Villalona Calero

PDF

Type of TP53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung-specific transgenic mice, Miguel Villalona Calero

Submissions from 2018

PDF

How I treat the young patient with multiple myeloma, Claudia Paba Prada

PDF

Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update, Michael Troner

PDF

EML4-ALK Rearrangement and Its Therapeutic Implications in Inflammatory Myofibroblastic Tumors, Fernando Vargas Madueno, Edwin Gould, Raul Valor, and Miguel Villalona Calero

PDF

Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung Cancer, Miguel Villalona Calero

PDF

Phase II randomized, double-blind, placebo-controlled study of tivantinib in men with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC), Miguel Villalona Calero

PDF

Predicting response to checkpoint inhibitors in melanoma beyond PD-L1 and mutational burden, Miguel Villalona Calero and Zuanel Diaz

Submissions from 2016

Global Overview of Colorectal Cancer ― Past, Present and Future, Antonio Ucar

PDF

Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination Repair, Miguel Villalona Calero